Clinical measurements, such as the levels of circulating metabolites, can be used to diagnose and monitor disease progression. These quantitative traits (also known as intermediate phenotypes) have been the basis of many genome-wide association studies (GWAS) 1 . Now, Kanai et al. 2 demonstrate pleiotropy (the sharing of risk alleles across multiple traits) 3 , genetic correlation and cell type specificity for quantitative traits as predictors of multiple complex diseases in a Japanese cohort. The results of this study, which incorporates data from GWAS of several complex diseases into a new GWAS of quantitative traits, indicate that clinical measurements can provide important insights into the genetics and aetiology of complex diseases.
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Kanai and colleagues initially examined the association between genetic variants and 58 quantitative traits in >160,000 individuals from the BioBank Japan Project 2,4-5 . These traits included blood pressure, echocardiography-related phenotypes, metabolic traits, serum protein and electrolyte levels, haematological indices, and the levels of circulating metabolites related to kidney and liver function. The GWAS identified 1,407 trait-associated loci for 53 of the quantitative traits. Interestingly, pleiotropy was observed for 88 loci across multiple trait categories (intercategorical pleiotrophy) and 225 loci across traits in a single category. The genetic loci that demonstrated the greatest pleiotropy allergic disease, autoimmune disease, infectious disease, haematological disease, psychiatric disorders, musculoskeletal disease, cancer and other complex diseases. A pairwise analysis demonstrated 68 statistically significant genetic correlations between the quantitative traits and the complex diseases. Interestingly, >75% of the correlations involved cardiometabolic diseases (type 2 diabetes mellitus, ischaemic stroke, cerebral aneurysm, myocardial infarction, peripheral artery disease and atrial fibrillation), which correlated with traits in seven of the measured trait categories (including metabolism, blood pressure and echocardiography). Although many of the associations were predictable, such as the relationship between ischaemic stroke and systolic blood pressure (SBP), notable correlations were observed between ischaemic stroke and uric acid, between myocardial infarction and the plasma albumin:globulin ratio, between urolithiasis and SBP, and between asthma and SBP. The researchers constructed a network from the matrix of genetic correlations that demonstrated distinctive clusters of biologically related phenotypes. Furthermore, the network revealed a close interrelationship between kidney-related, liver-related as well as haematological biomarkers and cardiometabolic diseases. These observations provide insights into expected and somewhat surprising relationships between genetic loci, quantitative traits and diseases.
Last, the quantitative trait and disease GWAS results were used together with cell included ALDH2 (aldehyde dehydrogenase 2), which was associated with 21 traits in 7 categories (including metabolic, kidney and blood pressure-related phenotypes); GCKR (glucokinase regulatory protein), which was associated with 18 traits in 7 categories (including kidney-related phenotypes); ABO (ABO blood group proteins α-1,3-N-acetylgalactosaminyltransferase and/or α-1,3-galactosyltransferase), which was associated with 15 traits in 6 categories (including haematological traits); and RGS12 (regulator of G protein signalling 12), which was associated with 9 traits in 6 categories (including kidney-related traits). A subsequent analysis of polygenic correlations across 57 of the original traits in addition to body mass index (BMI) and adult body height identified >170 genetic correlations with 100 intercategorical correlations between traits. The greatest number of statistically significant correlations was observed with BMI, which correlated with 22 traits in 7 categories, including blood pressure, total circulating protein and body height. The observed pleiotropic associations and correlations across quantitative traits indicate that these traits share common genetic pathways.
To explore the correlations between intermediate phenotypes and disease, the results of 30 case-control GWAS of complex diseases in Japanese individuals were incorporated into the analysis. The disease categories included metabolic disease, cardiovascular disease, 
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type-specific annotations for histone modifications for further analyses of the cell type specificity of human traits and diseases on the basis of heritability enrichment 2, [6] [7] . The initial analysis demonstrated heritability enrichments in ten major groups of cell types that are consistent with known biology. For example, groups of kidney cell types were enriched for estimated glomerular filtration rate. A subsequent analysis of 220 individual cell types identified 384 statistically significant heritability enrichments for 50 quantitative traits and diseases. Hierarchical cell type-based clustering of these heritability enrichments demonstrated that distinct clusters comprised related traits and cell types, with the most distinct cluster involving immune and haematopoi etic cell types enriched in immune-related diseases and traits. The researchers constructed a network matrix based on these clusters to highlight shared cell types involved in traits and diseases. The largest network was composed of clusters associated with whole-blood cell count, lymphocyte count and body height. These results provide some indication of the cell types that are causal in human disease.
The study by Kanai et al. provides potentially important insights into the relationships between genetic loci, intermediate phenotypes and diseases. Genetic loci can contain variants that are associated with multiple, sometimes distinct, quantitative traits (FIG. 1) . Similarly, associations were found between some genetic variants and complex diseases. The correlations observed between the GWAS of the traits and diseases provide evidence of previously unappreciated biological relationships. While many of the observed correlations between the GWAS of traits and diseases seem to have a similar biological origin (for example, the correlations between cerebral aneurysm and myocardial infarction with blood pressure-related traits), other correlations are less obvious (for example, urolithiasis and blood pressure-related traits) and have not been extensively studied or described 8 . Although the GWAS results identify potentially important genetic loci, it is important to note that these studies -by design -can only identify associations and do not yield a particular gene target or mechanism 1 . Hence, subsequent studies (that is, experiments in transgenic animals and other mechanistic studies) will be necessary to directly connect alterations in genetic sequence with differences in quantitative traits. Last, alterations in coding and non-coding regions of the genome alone are unlikely to fully explain common and complex diseases, as environmental factors can lead to epigenetic DNA modifications and alterations in RNA, protein and metabolite profiles, with resulting changes in physiological function 9 . In summary, Kanai et al. conducted a GWAS on a large non-European cohort to identify previously described and novel genetic loci for quantitative traits in Japanese individuals. A further incorporation of GWAS for complex diseases permitted the identification of pleiotropic loci, genetic correlations and cell type specificity. Taken together, these results confirm previous observations and provide novel information and insights into disease biology.
